Min Li to Antineoplastic Agents
This is a "connection" page, showing publications Min Li has written about Antineoplastic Agents.
Connection Strength
1.025
-
Editorial - Special issue on Fighting Pancreatic Cancer. Cancer Lett. 2017 07 10; 398:22-23.
Score: 0.361
-
Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer. Cancer Lett. 2015 Jul 10; 363(1):1-6.
Score: 0.314
-
Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces. 2021 Oct 27; 13(42):49614-49630.
Score: 0.123
-
An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A. 2019 11 12; 116(46):23264-23273.
Score: 0.108
-
Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer. Curr Med Chem. 2018; 25(22):2535-2544.
Score: 0.095
-
STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner. Clin Cancer Res. 2018 06 01; 24(11):2665-2677.
Score: 0.024